To evaluate the 2-year outcomes of trabeculo-canalectomy in Chinese patients with glaucoma secondary to iridocorneal endothelial syndrome (GS-ICE).
Approach:
Study Design: Retrospective study involving 26 GS-ICE patients treated with trabeculo-canalectomy and followed for 2 years, with outcomes assessed at multiple follow-up visits.
Surgical Procedure: Trabeculo-canalectomy performed without antimetabolites by the same experienced surgeon, following a standardized protocol.
Key Findings:
Postoperative mean IOP significantly reduced from 31.10 ± 11.00 mmHg preoperatively to 13.27 ± 2.68 mmHg at 1 week and remained lower at subsequent follow-ups (p < 0.001).
The number of postoperative anti-glaucoma medications decreased significantly, reaching 0 at all follow-up visits (p < 0.001).
Complete success rate at 2 years was 80.8% (p < 0.001), while conditional success was 11.5%.
Hyphema was the most common early complication (7.7%), self-resolving within the first week.
Interpretation:
Trabeculo-canalectomy demonstrates favorable outcomes in controlling IOP and reducing medication needs in GS-ICE patients over a 2-year period.
Limitations:
Retrospective design may introduce selection bias.
Small sample size of 26 patients limits generalizability.
Conclusion:
Trabeculo-canalectomy provides effective IOP control and reduces the need for anti-glaucoma medications with a low complication rate in GS-ICE patients over a 2-year period.
Forty-four years in, Heaton Eye is still learning, but its foundation hasn't changed. "We believe in the technologies we offer, we prepare our team for success, and we let the outcomes do the rest."
Analysis of more than 61,000 patients found higher odds of elevated loneliness scores among those reporting blindness and those with diabetic retinopathy, but not among patients with glaucoma or age-related macular degeneration.
